Anti-Bcl-2 antibody [E17] (Ab32124)
Apoptosis regulator Bcl-2, BCL2
用户验证的应用
推荐稀释比例
- IHC-P1/250 - 1/500 We do not recommend rat and mouse samples with IHC. Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB1/1000 We recommend using ab182858 for murine samples.
- IP1/50
详细信息
背景信息
What is this antibody validated in? Anti-Bcl-2 antibody [E17] (ab32124) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human samples. What is the molecular weight of Bcl-2? Anti-Bcl-2 [E17] (ab32124) specifically detects a band for Bcl-2 (UniProt: P10415) at a molecular weight of 26kDa. Trusted by the scientific community Anti-Bcl-2 [E17] (ab32124) was first used in a scientific publication in 2006 and has been cited over 1300 times in peer-reviewed journals. Reviewed by scientists Anti-Bcl-2 [E17] (ab32124) has over 10 independent reviews from customers. Specificity confirmed The specificity of Anti-Bcl-2 antibody [E17] (ab32124) has been confirmed by Immunocytochemistry testing in BCL2 Knockout Hap1 cells. Other related products We have a range of other formats of antibody clone [E17] also available for your convenience: ab32124, Carrier free - ab185002, Carrier free - ab242335, Alexa Fluor® 488 - ab311028, Alexa Fluor® 647 - ab311154, Alexa Fluor® 594 - ab311800, Alexa Fluor® 568 - ab313083, Alexa Fluor® 555 - ab313277, Alexa Fluor® 750 - ab321578 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Species reactivity Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (1360)
A Novel FGFR3-Targeting Antibody-Drug Conjugate Induces Tumor Cell Apoptosis through the cGAS-STING Pathway in Bladder Cancer.
一种新型的FGFR3靶向抗体-药物偶联物通过cGAS-STING通路诱导膀胱癌细胞凋亡。
TP53BP2 Promotes Placental Autophagy and Preeclampsia via G9a and DNMT1 Cooperatively Modulating E2F1.
TP53BP2 通过 G9a 和 DNMT1 协同调节 E2F1 促进胎盘自噬和先兆子痫。
Integrating single-cell and spatial transcriptomics to dissect mast-cell heterogeneity and arginine-metabolism-associated markers in BRCA.
整合单细胞和空间转录组学来解析 BRCA 中肥大细胞异质性和精氨酸代谢相关标志物。
Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment.
利用蛋白水解靶向嵌合体技术靶向降解组蛋白去乙酰化酶 8:一种有前景的胶质母细胞瘤治疗方法。
Naoxintong capsule decreases circulating exosomes of miR-382-5p to protect LPS-induced vascular endothelial cell injury by targeting STC1 in vitro.
钠心通胶囊通过靶向 STC1 在体外降低循环外泌体中 miR-382-5p 的含量,从而保护 LPS 诱导的血管内皮细胞损伤。
Moracin D Inhibits Gastric Cancer Progression Through B-Cell Lymphoma-2 (Bcl-2)-Mediated Cell Cycle Arrest and Apoptosis, Enhancing Chemotherapy Efficacy.
Moracin D 通过 B 细胞淋巴瘤-2 (Bcl-2) 介导的细胞周期阻滞和凋亡抑制胃癌进展,增强化疗疗效。
Acacetin Attenuates Lysophosphatidylcholine-Induced Vascular Smooth Muscle Cell Injury via Sirt1-Nrf2/p62 Signaling Axis.
阿卡西汀通过 Sirt1-Nrf2/p62 信号轴减弱溶血磷脂酰胆碱诱导的血管平滑肌细胞损伤。
Carnosic Acid Mediates Production of Reactive Oxygen Species to Regulate Mitogen-Activated Protein Kinase Pathway Phosphorylation and Induce Apoptosis in Human Breast Cancer Cells.
鼠尾草酸介导活性氧的产生,从而调节丝裂原活化蛋白激酶通路磷酸化并诱导人乳腺癌细胞凋亡。
Integrated multi-target pharmacology of ginseng in acute myeloid leukemia through single-cell sequencing, molecular docking, network pharmacology, and in vitro experiments.
通过单细胞测序、分子对接、网络药理学和体外实验,研究人参在急性髓系白血病中的综合多靶点药理作用。
Mesenchymal stem cell-derived miR-125b-1-3p-abundant exosomes alleviate osteoarthritis by modulating the KDM6B-H3K27me3-FOXM1 axis.
间充质干细胞衍生的富含 miR-125b-1-3p 的外泌体通过调节 KDM6B-H3K27me3-FOXM1 轴来缓解骨关节炎。
- 1
- 2
- 3
- 4
- 5
- 6
- 136